MTM Documentation & Clinical Communication 4 — Questions and Answers
Question 1: Which of the following is a required element of the written CMR summary that must be provided to the patient under CMS MTM program guidelines?
- A list of all pharmacy claims submitted to Medicare in the past year
- A cover letter, Personal Medication Record, and Medication Action Plan (Correct answer)
- The pharmacist's DEA registration number
- A formulary comparison of covered versus non-covered medications
Correct answer: A cover letter, Personal Medication Record, and Medication Action Plan
CMS requires CMR written summaries to include a cover letter explaining the MTM program, a complete PMR, and a patient-centered MAP.
Question 2: When communicating an urgent drug-related safety concern (e.g., critical drug interaction) to a prescriber, the MTM pharmacist should FIRST:
- Send a fax and wait for a response within 5 business days
- Contact the prescriber by phone immediately and document the communication (Correct answer)
- Notify the patient only and let them communicate with their physician
- Submit an incident report to CMS before contacting the prescriber
Correct answer: Contact the prescriber by phone immediately and document the communication
Urgent safety concerns require immediate verbal contact with the prescriber followed by written documentation to ensure prompt action and accountability.
Question 3: Proper documentation of a patient's health literacy level during MTM is important primarily because it:
- Determines the patient's insurance eligibility for MTM services
- Guides how the pharmacist tailors communication and written materials for the patient (Correct answer)
- Is required by law under the Americans with Disabilities Act
- Sets the billing tier for the MTM encounter
Correct answer: Guides how the pharmacist tailors communication and written materials for the patient
Documenting health literacy allows future care providers to use appropriately tailored communication strategies, improving comprehension and adherence.
Question 4: A pharmacist documents a 'Drug Without Indication' as a drug-related problem in an MTM note. Which additional documentation is MOST important to include?
- The cost of the unnecessary medication
- The specific medication identified, the basis for the finding, and the recommended action (Correct answer)
- A list of all formulary alternatives available
- The date the medication was first dispensed by the pharmacy
Correct answer: The specific medication identified, the basis for the finding, and the recommended action
DRP documentation must specify the offending agent, clinical evidence supporting the finding, and the pharmacist's recommended course of action.
Question 5: In MTM documentation, 'therapeutic duplication' should be recorded as a drug-related problem when:
- A patient takes two medications from different drug classes for the same condition
- Two or more medications provide the same pharmacological effect without added benefit (Correct answer)
- A generic and brand-name version of the same drug are dispensed simultaneously
- The prescriber orders the same drug from two different pharmacies intentionally
Correct answer: Two or more medications provide the same pharmacological effect without added benefit
Therapeutic duplication is defined as two or more medications providing the same therapeutic effect without demonstrated additive benefit, increasing adverse event risk.
Question 6: Which professional standard requires MTM pharmacists to document that they obtained informed consent before conducting a CMR?
- The Joint Commission Medication Management standards
- CMS MTM program eligibility rules requiring beneficiary agreement to participate (Correct answer)
- State pharmacy board licensure renewal requirements
- FDA medication guide distribution regulations
Correct answer: CMS MTM program eligibility rules requiring beneficiary agreement to participate
CMS MTM programs require that enrolled beneficiaries agree to participate; this beneficiary opt-in consent should be documented before conducting the CMR.
Question 7: After identifying a subtherapeutic dose during an MTM visit, a pharmacist documents a recommendation to increase the dose. The prescriber disagrees. The pharmacist should document:
- That the prescriber was wrong and escalate to the state board
- The recommendation made, the prescriber's response, and any agreed-upon monitoring plan (Correct answer)
- Only the prescriber's decision, removing the pharmacist's original recommendation
- That the issue was resolved without noting the clinical disagreement
Correct answer: The recommendation made, the prescriber's response, and any agreed-upon monitoring plan
Full documentation of the recommendation, prescriber's response, and any monitoring plan preserves the clinical record and supports ongoing collaborative care.
MTM Documentation & Clinical Communication 4
Which of the following is a required element of the written CMR summary that must be provided to the patient under CMS MTM program guidelines?